Nichols & Pratt Advisers LLP MA Has $8.38 Million Stock Holdings in Synopsys, Inc. $SNPS

Nichols & Pratt Advisers LLP MA raised its position in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 30.1% in the third quarter, according to its most recent filing with the SEC. The firm owned 16,991 shares of the semiconductor company’s stock after purchasing an additional 3,930 shares during the quarter. Nichols & Pratt Advisers LLP MA’s holdings in Synopsys were worth $8,383,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Alpine Bank Wealth Management grew its stake in Synopsys by 89.3% during the third quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after purchasing an additional 25 shares during the period. TFC Financial Management Inc. grew its position in Synopsys by 1,250.0% in the 3rd quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock valued at $27,000 after purchasing an additional 50 shares during the period. Millstone Evans Group LLC acquired a new position in shares of Synopsys during the third quarter valued at about $27,000. SOA Wealth Advisors LLC. acquired a new position in Synopsys during the 3rd quarter valued at about $28,000. Finally, McIlrath & Eck LLC purchased a new position in shares of Synopsys during the third quarter valued at approximately $29,000. 85.47% of the stock is owned by institutional investors.

Insider Buying and Selling at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at $8,221,058.34. The trade was a 17.01% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Janet Lee sold 250 shares of the firm’s stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the transaction, the insider owned 11,959 shares in the company, valued at $6,338,270. This represents a 2.05% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 4,157 shares of company stock worth $1,945,036. 0.62% of the stock is owned by insiders.

Synopsys Trading Down 1.6%

Shares of Synopsys stock opened at $457.89 on Tuesday. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The company has a 50 day simple moving average of $478.60 and a two-hundred day simple moving average of $500.20. The firm has a market cap of $87.60 billion, a PE ratio of 57.31, a PEG ratio of 3.87 and a beta of 1.12. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52.

Synopsys (NASDAQ:SNPSGet Free Report) last released its quarterly earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.11. The business had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The company’s revenue for the quarter was up 37.8% on a year-over-year basis. During the same quarter last year, the business posted $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on SNPS shares. Zacks Research upgraded shares of Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday, November 10th. Rosenblatt Securities upgraded Synopsys from a “neutral” rating to a “buy” rating and lowered their target price for the company from $605.00 to $560.00 in a research note on Tuesday, December 9th. Wall Street Zen raised shares of Synopsys from a “sell” rating to a “hold” rating in a research report on Saturday, December 13th. JPMorgan Chase & Co. lifted their price target on Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a research report on Thursday, December 11th. Finally, Wells Fargo & Company raised their target price on Synopsys from $445.00 to $500.00 and gave the stock an “equal weight” rating in a research note on Thursday, December 11th. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Synopsys currently has an average rating of “Moderate Buy” and a consensus price target of $553.57.

View Our Latest Stock Analysis on Synopsys

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Recommended Stories

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.